FDA to prioritize full approval for Pfizer COVID-19 vaccine
New COVID-19 vaccine warnings mean the system to report side effects is working
19 July 2021Many hit hard by pandemic now swamped by medical debt
19 July 2021FDA to prioritize full approval for Pfizer COVID-19 vaccine
(HealthDay)—Pfizer Inc. announced on Friday that the U.S. Food and Drug Administration has granted priority review to its COVID-19 vaccine, positioning the vaccine for full approval by January.
